Zimmer Biomet Holdings Future Growth
Future criteria checks 1/6
Zimmer Biomet Holdings is forecast to grow earnings and revenue by 11.8% and 4% per annum respectively. EPS is expected to grow by 12.8% per annum. Return on equity is forecast to be 15.9% in 3 years.
Key information
11.8%
Earnings growth rate
12.8%
EPS growth rate
| Medical Equipment earnings growth | 12.5% |
| Revenue growth rate | 4.0% |
| Future return on equity | 15.9% |
| Analyst coverage | Good |
| Last updated | 06 Feb 2025 |
Recent future growth updates
Recent updates
Investors Appear Satisfied With Zimmer Biomet Holdings, Inc.'s (NYSE:ZBH) Prospects
Feb 06
These 4 Measures Indicate That Zimmer Biomet Holdings (NYSE:ZBH) Is Using Debt Reasonably Well
Jan 10Zimmer Biomet: Back On Offense With Strong Cash Flow Outlook
Jan 05Zimmer Biomet Holdings (NYSE:ZBH) Is Due To Pay A Dividend Of $0.24
Dec 21At US$108, Is It Time To Put Zimmer Biomet Holdings, Inc. (NYSE:ZBH) On Your Watch List?
Dec 08Shareholders Can Be Confident That Zimmer Biomet Holdings' (NYSE:ZBH) Earnings Are High Quality
Nov 07Results: Zimmer Biomet Holdings, Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates
Nov 02Zimmer Biomet Holdings, Inc.'s (NYSE:ZBH) Share Price Not Quite Adding Up
Oct 03Zimmer Biomet: The Undervalued Titan Of Joint Replacements
Oct 02Zimmer Biomet Stock: Don't Jump In At The 52-Week Low
Sep 19We Like These Underlying Return On Capital Trends At Zimmer Biomet Holdings (NYSE:ZBH)
Sep 18Zimmer Biomet Holdings (NYSE:ZBH) Is Due To Pay A Dividend Of $0.24
Sep 02Zimmer Biomet Holdings (NYSE:ZBH) Seems To Use Debt Quite Sensibly
Aug 27Are Investors Undervaluing Zimmer Biomet Holdings, Inc. (NYSE:ZBH) By 45%?
Jul 15Investors Interested In Zimmer Biomet Holdings, Inc.'s (NYSE:ZBH) Earnings
Jul 02Zimmer Biomet: Brighter Prospects In H2 2024
Jul 02Zimmer Biomet Holdings (NYSE:ZBH) Has Affirmed Its Dividend Of $0.24
Jun 19When Should You Buy Zimmer Biomet Holdings, Inc. (NYSE:ZBH)?
Jun 05Zimmer Biomet Holdings' (NYSE:ZBH) Dividend Will Be $0.24
May 21Zimmer Biomet Holdings: Moving Along
May 17The Return Trends At Zimmer Biomet Holdings (NYSE:ZBH) Look Promising
May 02Is Zimmer Biomet Holdings (NYSE:ZBH) Using Too Much Debt?
Mar 20Zimmer Biomet Holdings (NYSE:ZBH) Will Pay A Dividend Of $0.24
Mar 02Zimmer Biomet Holdings' (NYSE:ZBH) Strong Earnings Are Of Good Quality
Feb 15What Does Zimmer Biomet Holdings, Inc.'s (NYSE:ZBH) Share Price Indicate?
Feb 11Zimmer Biomet: Weight Loss Drug Concerns Are Overblown
Feb 05Zimmer Biomet: Growth Acceleration Is Likely Driven By ROSA; Initiate With 'Buy'
Jan 20Zimmer Biomet Holdings: Visible Growth Drivers And Strong Execution
Dec 18Zimmer Biomet: Still Many Questions After A Solid Year So Far
Nov 26Zimmer Biomet Holdings: Growth Strategies For 2023 Instill Confidence
Sep 14Zimmer Biomet: Guidance Raise, Better Margins In 2024 Make It A Buy
Aug 11Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2027 | 8,655 | 1,377 | 2,092 | 2,022 | 6 |
| 12/31/2026 | 8,336 | 1,163 | 1,926 | 2,233 | 22 |
| 12/31/2025 | 7,971 | 1,064 | 1,133 | 1,440 | 24 |
| 12/31/2024 | 7,679 | 904 | 902 | 1,499 | N/A |
| 9/30/2024 | 7,596 | 1,084 | 992 | 1,582 | N/A |
| 6/30/2024 | 7,525 | 997 | 821 | 1,523 | N/A |
| 3/31/2024 | 7,452 | 964 | 807 | 1,502 | N/A |
| 12/31/2023 | 7,394 | 1,024 | 892 | 1,582 | N/A |
| 9/30/2023 | 7,279 | 474 | 548 | 1,237 | N/A |
| 6/30/2023 | 7,196 | 506 | 724 | 1,351 | N/A |
| 3/31/2023 | 7,108 | 450 | 858 | 1,355 | N/A |
| 12/31/2022 | 6,940 | 290 | 839 | 1,285 | N/A |
| 9/30/2022 | 6,892 | 366 | 970 | 1,406 | N/A |
| 6/30/2022 | 6,908 | 334 | 957 | 1,389 | N/A |
| 3/31/2022 | 6,889 | 325 | 1,078 | 1,490 | N/A |
| 12/31/2021 | 6,827 | 445 | 1,074 | 1,499 | N/A |
| 9/30/2021 | 7,135 | 834 | 1,164 | 1,559 | N/A |
| 6/30/2021 | 7,379 | 914 | 1,132 | 1,507 | N/A |
| 3/31/2021 | 6,842 | 563 | 618 | 1,000 | N/A |
| 12/31/2020 | 6,128 | -11 | 834 | 1,205 | N/A |
| 9/30/2020 | 7,065 | -152 | 762 | 1,203 | N/A |
| 6/30/2020 | 7,028 | 37 | 899 | 1,399 | N/A |
| 3/31/2020 | 7,791 | 377 | 1,008 | 1,753 | N/A |
| 12/31/2019 | 7,982 | 1,132 | 865 | 1,586 | N/A |
| 9/30/2019 | 7,928 | -90 | 830 | 1,542 | N/A |
| 6/30/2019 | 7,872 | -359 | 750 | 1,448 | N/A |
| 3/31/2019 | 7,891 | -308 | 1,087 | 1,541 | N/A |
| 12/31/2018 | 7,933 | -379 | 1,308 | 1,747 | N/A |
| 9/30/2018 | 7,930 | 1,753 | N/A | 1,771 | N/A |
| 6/30/2018 | 7,907 | 1,690 | N/A | 1,750 | N/A |
| 3/31/2018 | 7,849 | 1,689 | N/A | 1,797 | N/A |
| 12/31/2017 | 7,803 | 1,814 | N/A | 1,582 | N/A |
| 9/30/2017 | 7,748 | 652 | N/A | 1,807 | N/A |
| 6/30/2017 | 7,768 | 712 | N/A | 1,696 | N/A |
| 3/31/2017 | 7,752 | 497 | N/A | 1,635 | N/A |
| 12/31/2016 | 7,668 | 306 | N/A | 1,632 | N/A |
| 9/30/2016 | 7,604 | 363 | N/A | 1,468 | N/A |
| 6/30/2016 | 7,534 | 227 | N/A | 1,214 | N/A |
| 3/31/2016 | 6,767 | 84 | N/A | 1,031 | N/A |
| 12/31/2015 | 5,998 | 147 | N/A | 850 | N/A |
| 9/30/2015 | 5,287 | 174 | N/A | 742 | N/A |
| 6/30/2015 | 4,631 | 325 | N/A | 899 | N/A |
| 3/31/2015 | 4,646 | 670 | N/A | 956 | N/A |
| 12/31/2014 | 4,673 | 720 | N/A | 1,061 | N/A |
| 9/30/2014 | 4,691 | 802 | N/A | 999 | N/A |
| 6/30/2014 | 4,659 | 784 | N/A | 1,036 | N/A |
| 3/31/2014 | 4,646 | 764 | N/A | 971 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: ZBH's forecast earnings growth (11.8% per year) is above the savings rate (2.6%).
Earnings vs Market: ZBH's earnings (11.8% per year) are forecast to grow slower than the US market (14.8% per year).
High Growth Earnings: ZBH's earnings are forecast to grow, but not significantly.
Revenue vs Market: ZBH's revenue (4% per year) is forecast to grow slower than the US market (8.8% per year).
High Growth Revenue: ZBH's revenue (4% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: ZBH's Return on Equity is forecast to be low in 3 years time (15.9%).
Discover growth companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/06 08:18 |
| End of Day Share Price | 2025/02/06 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Zimmer Biomet Holdings, Inc. is covered by 61 analysts. 24 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| David Toung | Argus Research Company |
| Stephan Gasteyger | Atlantic Equities LLP |
| Jeffrey Johnson | Baird |